Literature DB >> 32171526

The role of propofol hydroxyl group in 5-lipoxygenase recognition.

Koichi Yuki1, Weiming Bu2, Roderic G Eckenhoff2, Takehiko Yokomizo3, Toshiaki Okuno4.   

Abstract

Propofol is a clinically important intravenous anesthetic. We previously reported that it directly inhibited 5-lipoxygenase (5-LOX), a key enzyme for leukotriene biosynthesis. Because the hydroxyl group in propofol (propofol 1-hydroxyl) is critical for its anesthetic effect, we examined if its presence would be inevitable for 5-lipoxygenase recognition. Fropofol is developed by substituting the hydroxy group in propofol with fluorine. We found that propofol 1-hydroxyl was important for 5-lipoxygenase recognition, but it was not absolutely necessary. Azi-fropofol bound to 5-LOX at one of the two propofol binding sites of 5-LOX (pocket around Phe-187), suggesting that propofol 1-hydroxyl is important for 5-LOX inhibition at the other propofol binding site (pocket around Val-431). Interestingly, 5-hydroperoxyeicosatetraenoic acid (5-HpETE) production was significantly increased by stimulation with calcium ionophore A23187 in HEK293 cells expressing 5-LOX, suggesting that the fropofol binding site is important for the conversion from 5-HpETE to leukotriene A4. We also indicated that propofol 1-hydroxyl might have contributed to interaction with wider targets among our body.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5-lipoxygenase; Fropofol; Propofol; Propofol 1-hydroxyl

Mesh:

Substances:

Year:  2020        PMID: 32171526      PMCID: PMC7167355          DOI: 10.1016/j.bbrc.2020.03.037

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Distinct molecular targets for the central respiratory and cardiac actions of the general anesthetics etomidate and propofol.

Authors:  Anja Zeller; Margarete Arras; Anelise Lazaris; Rachel Jurd; Uwe Rudolph
Journal:  FASEB J       Date:  2005-07-26       Impact factor: 5.191

2.  Glutathione peroxidase is neither required nor kinetically competent for conversion of 5-HPETE to 5-HETE in rat PMN lysates.

Authors:  M T Skoog; J S Nichols; B L Harrison; J S Wiseman
Journal:  Prostaglandins       Date:  1986-03

3.  The structure of human 5-lipoxygenase.

Authors:  Nathaniel C Gilbert; Sue G Bartlett; Maria T Waight; David B Neau; William E Boeglin; Alan R Brash; Marcia E Newcomer
Journal:  Science       Date:  2011-01-14       Impact factor: 47.728

4.  Identification of the Substrate Access Portal of 5-Lipoxygenase.

Authors:  Sunayana Mitra; Sue G Bartlett; Marcia E Newcomer
Journal:  Biochemistry       Date:  2015-10-08       Impact factor: 3.162

5.  Molecular mechanism of anesthetic-induced depression of myocardial contraction.

Authors:  Tao Meng; Weiming Bu; Xianfeng Ren; Xinzhong Chen; Jingui Yu; Roderic G Eckenhoff; Wei Dong Gao
Journal:  FASEB J       Date:  2016-05-11       Impact factor: 5.191

6.  The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages.

Authors:  A Rossi; C Pergola; A Koeberle; M Hoffmann; F Dehm; P Bramanti; S Cuzzocrea; O Werz; L Sautebin
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

7.  Propofol modulates activation and desensitization of GABAA receptors in cultured murine hippocampal neurons.

Authors:  B A Orser; L Y Wang; P S Pennefather; J F MacDonald
Journal:  J Neurosci       Date:  1994-12       Impact factor: 6.167

8.  I-TASSER server for protein 3D structure prediction.

Authors:  Yang Zhang
Journal:  BMC Bioinformatics       Date:  2008-01-23       Impact factor: 3.169

9.  Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase.

Authors:  Helmut Pein; Alexia Ville; Simona Pace; Veronika Temml; Ulrike Garscha; Martin Raasch; Khaled Alsabil; Guillaume Viault; Chau-Phi Dinh; David Guilet; Fabiana Troisi; Konstantin Neukirch; Stefanie König; Rosella Bilancia; Birgit Waltenberger; Hermann Stuppner; Maria Wallert; Stefan Lorkowski; Christina Weinigel; Silke Rummler; Marc Birringer; Fiorentina Roviezzo; Lidia Sautebin; Jean-Jacques Helesbeux; Denis Séraphin; Alexander S Mosig; Daniela Schuster; Antonietta Rossi; Pascal Richomme; Oliver Werz; Andreas Koeberle
Journal:  Nat Commun       Date:  2018-09-20       Impact factor: 14.919

10.  Volatile anesthetics isoflurane and sevoflurane directly target and attenuate Toll-like receptor 4 system.

Authors:  Toshiaki Okuno; Sophia Koutsogiannaki; Lifei Hou; Weiming Bu; Umeharu Ohto; Roderic G Eckenhoff; Takehiko Yokomizo; Koichi Yuki
Journal:  FASEB J       Date:  2019-11-02       Impact factor: 5.834

View more
  2 in total

1.  Propofol directly binds to and inhibits TLR7.

Authors:  Sophia Koutsogiannaki; Weiming Bu; Wiriya Maisat; Mariel Manzor; Zhikuan Zhang; Umeharu Ohto; Roderic G Eckenhoff; Koichi Yuki
Journal:  FASEB J       Date:  2022-08       Impact factor: 5.834

2.  Propofol Prevents the Growth, Migration, Invasion, and Glycolysis of Colorectal Cancer Cells by Downregulating Lactate Dehydrogenase Both In Vitro and In Vivo.

Authors:  Zhichao Wu; Han Wang; Zu-An Shi; Yalan Li
Journal:  J Oncol       Date:  2022-04-30       Impact factor: 4.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.